Banner Sun Health Research Institute

Recent papers from Banner Sun Health Research Institute

1. Plasma and CSF neurofilament light chain measured by Simoa and Lumipulse: an inter-platform comparison across neurological disordersClinical Chemistry and Laboratory Medicine (CCLM) · 2026
2. The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's DiseaseAnnals of Clinical and Translational Neurology · 2026
3. Global and regional amyloid-β in explaining APOE-ε4 and sex associations with medial temporal tau: a neuropathology studyActa Neuropathologica · 2026
4. Sex differences in locus coeruleus structure and function across the adult lifespan: effects of APOE, Alzheimer’s disease pathology, and estrogen levelsAlzheimer s Research & Therapy · 2026
5. Locus coeruleus activity is related to sleep and 24-h rest-activity rhythms in the context of plasma Alzheimer’s disease markers: a 7T MRI study of older individualsAlzheimer s Research & Therapy · 2026
6. Evaluation of plasma neurofilament and glial fibrillary acidic protein to predict or detect amyloid related imaging abnormalitiesAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 2026
7. Sex-Divergent Patterns in Hippocampal and Cortical NMDA Receptor Density Across the Alzheimer’s Disease ContinuumInternational Journal of Molecular Sciences · 2026
8. Blood proteomics of menopause map to brain aging and dementia riskNature Medicine · 2026
9. Brain‐derived plasma p‐tau217 shows enhanced dynamic range for Alzheimer's disease neuropathological changeAlzheimer s & Dementia · 2026
10. EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer DiseaseNeurology · 2026
11. Single cell transcriptomics reveals enrichment of predicted aggregation-prone alpha-synuclein isoforms across synucleinopathiesnpj Parkinson s Disease · 2026
12. Network-based analyses identify GFAP as a cross-domain hub linking synaptic, neuronal, and inflammatory CSF markers in Alzheimer’s diseaseScientific Reports · 2026
13. Performance of upper-arm capillary blood collection for Alzheimer’s disease and central nervous system biomarkers: comparison of Tasso+ and venous plasma2026
14. Clinical and Biologic Characterization of a 3-Level Centiloid-Based Classification of Amyloid PETJournal of Nuclear Medicine · 2026
15. Plasma Biomarkers for Neocortical Tau BurdenJAMA Neurology · 2026
16. Lifestyle and psychosocial protective factors drive healthy aging and modulate inflammatory and metabolic pathwaysGeroScience · 2026
17. Increased Binding of [ ¹⁸ F]Nifene, a PET Imaging Probe for α4β2* Nicotinic Acetylcholinergic Receptors in Hippocampus–Subiculum of Postmortem Human Parkinson's Disease BrainSynapse · 2026
18. Metabolism Pathway Blood Proteomic Differences in Lewy Body Dementia Compared to Alzheimer’s DiseaseInternational Journal of Molecular Sciences · 2026
19. Exploring longitudinal relationships among Alzheimer's disease biomarkersAlzheimer s & Dementia · 2026
20. Spectrum of amyloid-related imaging abnormalities associated with aducanumab treatment: a case series reportBMC Neurology · 2026